The antihypertensive effect of verapamil 200 mg b.i.d. was compared with that of verapamil 120 mg t.i.d. in a double-blind crossover study in eight out-patients with essential hypertension. The mean supine blood pressure measured before the morning dose was 150/87 mm Hg in patients treated with verapamil 200 mg b.i.d. and 151/87 mm Hg in those treated with verapamil 120 mg t.i.d. The recently reported prolonged half-life and accumulation of verapamil during steady-state conditions explains the lasting antihypertensive effect with the twice-daily dose regimen. Such a twice daily dose regimen is presumed to be more convenient to the patients and thus improve their compliance.
Get full access to this article
View all access options for this article.
References
1.
FreedmanBS (1981) Verapamil kinetics in normal subjects and patients with coronary artery spasm. Clinical Pharmacology and Therapeutics30, 644
2.
KatesRE (1981) Verapamil disposition kinetics in chronic atrial fibrillation. Clinical Pharmacology and Therapeutics30, 44
3.
LearyWPAsmalAC (1979) Treatment of hypertension with verapamil. Current Therapeutic Research25, 747
4.
SchwartzJB (1982) Prolongation of verapamil elimination kinetics during chronic oral administration. American Heart Journal104, 198
5.
ShandDG (1981) Reduced verapamil clearance during long-term oral administration. Clinical Pharmacology and Therapeutics30, 701
